Translational Development Acquisition Corp. Ordinary Shares Market Cap ($208.88 Million)
Market Cap & Net Worth: Translational Development Acquisition Corp. Ordinary Shares (TDAC)
Translational Development Acquisition Corp. Ordinary Shares market cap. Translational Development Acquisition Corp. Ordinary Shares (NASDAQ:TDAC) has a market capitalization of $208.88 Million ($208.88 Million) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16181 globally and #3864 in its home market, demonstrating a 0.09% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Translational Development Acquisition Corp. Ordinary Shares's stock price $10.82 by its total outstanding shares 19308802 (19.31 Million). Also see how efficiently does Translational Development Acquisition Co generate cash for how efficiently the company converts equity into cash flow.
Translational Development Acquisition Corp. Ordinary Shares Market Cap History (2025–2026)
Translational Development Acquisition Corp. Ordinary Shares market cap history from 2025 to 2026. Data shows growth from $202.55 Million to $208.92 Million (4.68% CAGR). Check today's stock price for Translational Development Acquisition Co for real-time trading data and today's change.
Translational Development Acquisition Corp. Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Translational Development Acquisition Corp. Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore TDAC net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TDAC by Market Capitalization
Companies near Translational Development Acquisition Corp. Ordinary Shares in the global market cap rankings as of November 1, 2026. Also see Translational Development Acquisition Co (TDAC) total assets for a full breakdown of the balance sheet.
Key companies related to Translational Development Acquisition Corp. Ordinary Shares by market ranking:
- Twenty One Capital, Inc. (NYSE:XXI): Ranked #6082 globally with a market cap of $1.90 Billion USD.
- Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ:DMII): Ranked #10570 globally with a market cap of $647.19 Million USD.
- Ares Acquisition Corporation II (NYSE:AACT): Ranked #11034 globally with a market cap of $587.05 Million USD.
- Voyager Acquisition Corp (NASDAQ:VACH): Ranked #11434 globally with a market cap of $541.25 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #6082 | Twenty One Capital, Inc. | NYSE:XXI | $1.90 Billion | $5.48 |
| #10570 | Drugs Made In America Acquisition II Corp. Ordinary Shares | NASDAQ:DMII | $647.19 Million | $10.20 |
| #11034 | Ares Acquisition Corporation II | NYSE:AACT | $587.05 Million | $9.49 |
| #11434 | Voyager Acquisition Corp | NASDAQ:VACH | $541.25 Million | $24.79 |
Market Capitalization of Translational Development Acquisition Corp. Ordinary Shares (2025–2026)
Market capitalization of Translational Development Acquisition Corp. Ordinary Shares from 2025 to today. Between 2025 and today, Translational Development Acquisition Corp. Ordinary Shares's market cap moved from $202.55 Million to $ 208.92 Million, with a yearly change of 4.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $208.92 Million | +3.15% |
| 2025 | $202.55 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 1st, 2026 the market cap of Translational Development Acquisition Corp. Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $208.88 Million USD |
| MoneyControl | $208.88 Million USD |
| MarketWatch | $208.88 Million USD |
| marketcap.company | $208.88 Million USD |
| Reuters | $208.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Translational Development Acquisition Corp. Ordinary Shares
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.